United States - English - NLM (National Library of Medicine)

attix pharmaceuticals - dihydrostreptomycin sulfate (unii: t7d4876iue) (dihydrostreptomycin sulfate - unii:t7d4876iue) -

Ireland - English - HPRA (Health Products Regulatory Authority)

alfasan nederland b.v - dihydrostreptomycin sulfate - solution for injection - 25 per cent - dihydrostreptomycin - bovine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - streptomycin sulfate, dihydrostreptomycin sulfate - solution for injection - per cent - streptomycin qj01ga90 dihydrostreptomycin - bovine, ovine, porcine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - streptomycin sulfate, dihydrostreptomycin sulfate - solution for injection - per cent - streptomycin qj01ga90 dihydrostreptomycin - bovine, ovine, porcine - antibacterial

United States - English - NLM (National Library of Medicine)

xgen pharmaceuticals djb, inc. - streptomycin sulfate (unii: cw25ikj202) (streptomycin - unii:y45qso73ob) - streptomycin 1 g - streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below: - mycobacterium tuberculosis: the advisory council for the elimination of tuberculosis, the american thoracic society, and the center for disease control recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (inh), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of inh or rifampin resistance is very low. the need for a fourth drug should be reassessed when the results of susceptibility testing are known. in the past when the national rate of primary drug resistance to isoniazid was known to be less than 4% and was either stable or declining, therapy with two and three drug regimens was considered adequate. if community rates of inh resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be co

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - dihydrostreptomycin sulfate - unknown - dihydrostreptomycin sulfate antibiotic active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

wg critical care, llc - penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c), dihydrostreptomycin sulfate (unii: t7d4876iue) (dihydrostreptomycin - unii:p2i6r8w6ua) - penicillin g 1000000 [iu] in 10 ml - for intramammary use to reduce the frequency of existing infection and to prevent new infections with staphylococcus aureus in dry cows. indicaciones: uso intramamario para reducir la frecuencia de la infección existente y prevenir nuevas infecciones por staphylococcus aureus en vacas secas.

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o box 16633-00620 nairobi, kenya - streptomycin sulphate - powder for suspension for injection - streptomycin (as sulphate) bp 1g/vial - antibacterials for systemic use: aminoglycosides

Kenya - English - Pharmacy and Poisons Board

medisel kenya ltd p.o box 540-01000 thika - streptomycin sulfate - injection - streptomycin sulfate1 gm - antibacterials for systemic use: aminoglycosides

Kenya - English - Pharmacy and Poisons Board

macleods pharmaceuticals limited 304 church road andheri-kurla andheri ( east) - streptomycin sulphate for injection 1 g - powder for injection - streptomycin sulphate bp - antibacterials for systemic use: streptogramins